???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Francisco J Miranda Rodrigues Cruz

Nomes de citação

  • Cruz, Francisco

Identificadores de autor

Ciência ID
9913-27D5-EBA2
ORCID iD
0000-0003-4551-514X

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica - Urologia e Nefrologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Francês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador proficiente (C1)
Formação
Grau Classificação
2000
Concluído
 Chefe de Serviço de Urologia (Outros)
Especialização em Urologia
Governo da República Portuguesa Ministério da Saúde, Portugal
 18 valores
1997
Concluído
 Urologia (Título de Agregado)
Universidade do Porto Faculdade de Medicina, Portugal
 Aprovado por maioria
1993
Concluído
 Medicina (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"Morfologia dos aferentes primários finos nas lâminas I e II da medula espinal" (TESE/DISSERTAÇÃO)
 Aprovado por unanimidade, com Distinção e Louvor
1990
Concluído
 Urologia (Título de especialista)
Especialização em Urologia
Ordem dos Médicos, Portugal
 19 valores
1979
Concluído
 Medicina (Licenciatura)
Universidade do Porto Faculdade de Medicina, Portugal
 17 Valores
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
1992 - Atual Investigador (Investigação) Universidade do Porto Faculdade de Medicina, Portugal
1997 - 2009 Investigador (Investigação) Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2021/06/01 - Atual Professor Catedrático (Docente Universitário) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Faculdade de Medicina, Portugal
2004 - 2006 Professor Associado (Docente Universitário) Universidade do Porto Faculdade de Medicina, Portugal

Cargos e Funções

Categoria Profissional
Instituição de acolhimento 		Empregador
2018/10/04 - Atual Vice-Presidente Universidade do Porto Faculdade de Medicina, Portugal
Universidade do Porto Faculdade de Medicina, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2021 - Atual PhD mentor of Luís Vale Universidade do Porto Faculdade de Medicina, Portugal
2020 - Atual PhD co-mentor of Pedro Mendes Universidade do Porto Faculdade de Medicina, Portugal
2020 - Atual PhD mentor of Margarida Manso Universidade do Porto Faculdade de Medicina, Portugal
2010 - Atual Group Leader Translational Neurourology IBMC-I3S Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2004 - Atual Regent of the urology discipline Universidade do Porto Faculdade de Medicina, Portugal
2006 - 2021 Invited Full Professor of Urology Universidade do Porto Faculdade de Medicina, Portugal
2015 - 2020 PhD mentor of Tiago Lopes Universidade do Porto Faculdade de Medicina, Portugal
2014 - 2019 PhD mentor of Raquel Oliveira Universidade do Porto Faculdade de Medicina, Portugal
2002 - 2018 Urology service director Universidade do Porto Faculdade de Medicina, Portugal
2010 - 2015 PhD mentor of Rui Oliveira Universidade do Porto Faculdade de Medicina, Portugal
2010 - 2015 PhD mentor of Rui Pinto Universidade do Porto Faculdade de Medicina, Portugal
2008 - 2013 PhD mentor of Nuno Tomada Universidade do Porto Faculdade de Medicina, Portugal
2008 - 2013 PhD mentor of Ana Coelho Universidade do Porto Faculdade de Medicina, Portugal
2008 - 2013 PhD co-mentor of Bárbara Frias Universidade do Porto Faculdade de Medicina, Portugal
2008 - 2012 PhD mentor of João Alturas da Silva Universidade do Porto Faculdade de Medicina, Portugal
2005/03/02 - 2010/03/02 PhD mentor of Ana Charrua Universidade do Porto Faculdade de Medicina, Portugal
2005 - 2008 Orientador do Doutoramento em Medicina de Carlos Silva Universidade do Porto Faculdade de Medicina, Portugal
2002 - 2006 PhD mentor of Paulo Dinis dos Santos de Oliveira Universidade do Porto Faculdade de Medicina, Portugal
2001 - 2006 PhD mentor of Célia Duarte Cruz Universidade do Porto Faculdade de Medicina, Portugal
1998 - 2003 PhD mentor of António Avelino Universidade do Porto Faculdade de Medicina, Portugal
Projetos

Bolsa

Designação Financiadores
2008 - 2010 Influência do NGF sobre o receptor TRPV1 num modelo animal de inflamação crónica da bexiga
APU 2008
Investigador responsável
Concluído

Projeto

Designação Financiadores
2018/04 - 2023/03 Understanding chronic pain and improving its treatment
IMI Pain Care 777500 project
 European Commission Seventh Framework Programme for Research and Technological Development
2018/04 - 2023/03 Improving the care of patients suffering from acute or chronic pain
777500
Co-Investigador Responsável (Co-IR)
Innovative Medicines Initiative, Bélgica
 European Commission
2020 - 2023 OVADER
19733OVADER
Investigador responsável
Concluído
2014 - 2023 Sympathetic nervous system dysfunction is a trigger to BPS/IC symptoms development
N/A
Investigador
Instituto de Biologia Molecular e Celular, Portugal
Concluído
2017 - 2020 Effect of two different doses of Rec0/0438 administered by intravesical instillation in patients with NDO and spinal cord injury
Nº EudraCT: 2017-000905-19
Investigador responsável
Concluído
2016 - 2019 Projecto Serenity
EudraCT :2014-001013-81
Investigador responsável
Concluído
2016 - 2018 Human Urethra
Human Urethra
Investigador
Concluído
2016 - 2018 CONTENT study
NCT02660138/NCT02660359
Investigador responsável
Concluído
2014 - 2018 ProBaBle
EudraCT: 2014-001-0013-81
Investigador responsável
Concluído
2005 - 2017 DIGNITY
NCT 00461292
Investigador responsável
Concluído
2014 - 2016 UNIOM
APU 2014
Co-Investigador Responsável (Co-IR)
2014/01 - 2014/12 Biomarkers and mechanisms of Interstitial Cystitis
Provided by PTCRIS: 133310
133310
 Fundação para a Ciência e a Tecnologia, I.P.
2011 - 2014 AMARANTH
EudraCT: 2011/004555/39
Investigador responsável
Concluído
2011 - 2013 SIRE
Eudract No.: 2011-000045-20
Investigador responsável
Concluído
2008/12 - 2012/05 Combating Incontinence: From basic science to clinical practice
FP7-HEALTH-223234
 Directorate-General for Research and Innovation
2008 - 2012 Importância do BDNF na hiperactividade vesical. Estudo experimental no rato.
APU-JABA 2008
Investigador responsável
Concluído
2005/03 - 2008/04 Sensory mechanisms of overactive bladder
55983
Provided by PTCRIS: 55983
Investigador responsável
Fundação para a Ciência e a Tecnologia, I.P.
2001 - 2004 Role of sensory neurons expressing the vanilloid receptor in urinary and articular pathology. An experimental and clinical study
32466/99
Investigador responsável
Concluído
1999 - 2001 Contribution of type C primary afferents in the development of vesical instability. Experimental study in rat.
Merck Sharp and Dome & APU
Investigador responsável
Concluído
1995 - 1998 Selective desensitization of the sensory innervation of the bladder by neurotoxins of the vanilloid type
PECS/C/SAU/185/95
Investigador responsável
Concluído
1988 - 1992 Immunocytochemistry study of neurotransmitters and opioids of the primary sensitive area of the spinal cord
JNICT, projecto nº 87190 IMU
Investigador
Concluído
1985 - 1989 Mechanisms of Pain Transmission and Control of the Spinal Cord
Fundação Volkswagen
Investigador
Concluído

Outro

Designação Financiadores
2016 - 2019 Porto Neuroscience and Neurological Disease Research Initiative at I3S - Porto NeuroDrive@I3S
Norte2020
Investigador responsável
Concluído
Produções

Publicações

Artigo em revista
  1. José Medina-Polo; Salvador Arlandis-Guzmán; Roberto Martínez-García; Bárbara Padilla-Fernández; David Manuel Castro-Díaz; Francisco Cruz; Carlos Errando-Smet; et al. "Position of the Ibero-American Society of Neurourology and Urogynecology (SINUG) on the urodynamics (UDS) in women undergoing surgical treatment for stress urinary incontinence (SUI)". Continence (2024): https://doi.org/10.1016/j.cont.2024.101714.
    10.1016/j.cont.2024.101714
  2. Guldal Inal; Dick Janssen; Naside Mangir; Francisco Cruz; Ana Charrua. "Current clinical status of IC/BPS and what the future holds in basic & translational science". Continence (2024): https://doi.org/10.1016/j.cont.2024.101338.
    10.1016/j.cont.2024.101338
  3. Margarida Manso; João Diogo Soares; Margarida Henriques; Francisco Botelho; Carlos Silva; Francisco Cruz. "Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence". Toxins (2024): https://doi.org/10.3390/toxins16080332.
    10.3390/toxins16080332
  4. Luís Vale; Francisco Cruz; Ana Charrua. "Detrusor Overactivity After Partial Bladder Outlet Obstruction Is Associated With High Urinary Adenosine Triphosphate Levels in Female Wistar Rats". International Neurourology Journal (2024): https://doi.org/10.5213/inj.2346196.098.
    10.5213/inj.2346196.098
  5. Téllez, Carlos; Diego, Rodrigo; Szczesniewski, Juliusz; Giammò, Alessandro; González-Enguita, Carmen; Schönburg, Sandra; Queissert, Fabian; et al. "Results of Adjustable Trans-Obturator Male System for Stress Urinary Incontinence after Transurethral Resection or Holmium Laser Enucleation of the Prostate: International Multicenter Study". Journal of clinical medicine (2024): https://europepmc.org/articles/PMC11354669.
    10.3390/jcm13164628
  6. Ewerton, Flavio; Cruz, Francisco; Kapp, Moritz; Klein, Stefan; Roehm, Petra; Chapple, Christopher. "Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study". European urology focus (2024): https://doi.org/10.1016/j.euf.2023.07.008.
    10.1016/j.euf.2023.07.008
  7. Pina-Vaz, Teresa; Silva, Alberto C; Silva, Carlos; Miranda, Isabel; Cruz, Francisco; Silva, João A. "The urinary and prostatic microbiome in non-neurogenic male LUTS/BPH: A systematic review". Neurourology and urodynamics (2024): https://doi.org/10.1002/nau.25530.
    10.1002/nau.25530
  8. Abreu-Mendes, Pedro; Dias, Diogo; Magno, Francisca; Silva, Guilherme; Rodrigues-Fonseca, José; Dinis, Paulo; Cruz, Francisco; Pinto, Rui Almeida. "A Pilot Study of Functional Brain Magnetic Resonance Imaging in BPS/IC Patients: Evidence of Central Sensitization". Urology research & practice (2024): https://doi.org/10.5152/tud.2024.23209.
    10.5152/tud.2024.23209
  9. Angulo, Javier C; Giammò, Alessandro; Queissert, Fabian; Schönburg, Sandra; González-Enguita, Carmen; Gonsior, Andreas; Romero, Antonio; et al. "The effectiveness of adjustable trans-obturator male system (ATOMS) in radiated patients is reduced: A propensity score-matched analysis". BJUI compass (2024): https://europepmc.org/articles/PMC11019248.
    10.1002/bco2.329
  10. Matos, Rita; Santos-Leite, Liliana; Cruz, Francisco; Charrua, Ana. "Early in life stressful events induce chronic visceral pain and changes in bladder function in adult female mice through a mechanism involving TRPV1 and alpha 1A adrenoceptors". Neurourology and urodynamics (2024): https://doi.org/10.1002/nau.25376.
    10.1002/nau.25376
  11. Francisco Cruz; Natalya Danchenko; Kyle Fahrbach; Andreas Freitag; Jialu Tarpey; John Whalen. "Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison". Journal of Medical Economics (2023): https://doi.org/10.1080/13696998.2023.2165366.
    10.1080/13696998.2023.2165366
  12. Fawzy Farag; N.I. Osman; K.H. Pang; D. Castro-Diaz; C.R. Chapple; F. Cruz; X. Gamé; et al. "Complications of Synthetic Midurethral Slings: Is There a Relevant Discrepancy Between Observational Data and Clinical Trials?". European Urology Focus (2023): http://dx.doi.org/10.1016/j.euf.2023.11.002.
    10.1016/j.euf.2023.11.002
  13. Margarida Manso; Botelho F; Bulhões C; Cruz F; Pacheco-Figueiredo L. "Self-reported urinary incontinence in women is higher with increased age, lower educational level, lower income, number of comorbidities, and impairment of mental health. Results of a large, population-based, national survey in Portugal.". World journal of urology (2023): https://doi.org/10.1007/s00345-023-04677-5.
    10.1007/s00345-023-04677-5
  14. Michel Wyndaele; Ana Charrua; François Hervé; Patrik Aronsson; Luke Grundy; Vik Khullar; Alan Wein; et al. "Beyond the urothelium: Interplay between autonomic nervous system and bladder inflammation in urinary tract infection, bladder pain syndrome with interstitial cystitis and neurogenic lower urinary tract dysfunction in spinal cord injury—ICI-RS 2023". Neurourology and Urodynamics (2023): https://doi.org/10.1002/nau.25310.
    10.1002/nau.25310
  15. Javier Angulo; Téllez C; Giammò A; González-Enguita C; Schoenburg S; Fabian Queissert; Juliusz Jan Szczesniewski; et al. "Results of Adjustable Trans-Obturator Male System in Patients with Prostate Cancer Treated with Prostatectomy and Radiotherapy: A Multicenter Study.". Journal of clinical medicine (2023): https://europepmc.org/articles/PMC10380664.
    10.3390/jcm12144721
  16. Francisco Cruz. "Re: Single-incision Mini-slings for Stress Urinary Incontinence in Women". European Urology (2023): http://dx.doi.org/10.1016/j.eururo.2023.03.007.
    10.1016/j.eururo.2023.03.007
  17. Coxon L; Vollert J; Perro D; Lunde CE; Ferreira-Gomes J; Charrua A; Abreu-Mendes P; et al. "Comprehensive quantitative sensory testing shows altered sensory function in women with chronic pelvic pain: results from the Translational Research in Pelvic Pain (TRiPP) Study.". Pain (2023): http://europepmc.org/abstract/med/37289573.
    10.1097/j.pain.0000000000002955
  18. Demetriou L; Krassowski M; Abreu Mendes P; Garbutt K; Vitonis AF; Wilkins E; Coxon L; et al. "Clinical profiling of specific diagnostic subgroups of women with chronic pelvic pain.". Frontiers in reproductive health (2023): http://europepmc.org/abstract/med/37325239.
    10.3389/frph.2023.1140857
  19. Ana Catarina Neto; Mariana Santos-Pereira; Pedro Abreu-Mendes; Delminda Neves; Henrique Almeida; Francisco Cruz; Ana Charrua. "The Unmet Needs for Studying Chronic Pelvic/Visceral Pain Using Animal Models". Biomedicines (2023): https://doi.org/10.3390/biomedicines11030696.
    10.3390/biomedicines11030696
  20. Michel, Martin C; Cardozo, Linda; Chermansky, Christopher J; Cruz, Francisco; Igawa, Yasuhiko; Lee, Kyu-Sung; Sahai, Arun; Wein, Alan J; Andersson, Karl-Erik. "Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders". Pharmacological reviews (2023): https://doi.org/10.1124/pharmrev.121.000523.
    10.1124/pharmrev.121.000523
  21. Pedro Abreu-Mendes; António Ferrão-Mendes; Francisco Botelho; Francisco Cruz; Rui Pinto. "Effect of Intratrigonal Botulinum Toxin in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Long-Term, Single-Center Study in Real-Life Conditions". Toxins (2022): https://doi.org/10.3390/toxins14110775.
    10.3390/toxins14110775
  22. Pedro Abreu-Mendes; Aurora Costa; Ana Charrua; Rui Almeida Pinto; Francisco Cruz. "The Role of Urinary VEGF in Observational Studies of BPS/IC Patients: A Systematic Review". Diagnostics 12 5 (2022): 1037-1037. https://doi.org/10.3390/diagnostics12051037.
    10.3390/diagnostics12051037
  23. Kennelly M; Cruz F; Herschorn S; Abrams P; Onem K; Solomonov VK; Del Rosario Figueroa Coz E; et al. "Efficacy and Safety of AbobotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Incontinence Performing Regular Clean Intermittent Catheterization: Pooled Results from Two Phase 3 Randomized Studies (CONTENT1 and CONTENT2).". European urology (2022): http://europepmc.org/abstract/med/35400537.
    10.1016/j.eururo.2022.03.010
  24. Luís Vale; Ana Charrua; Helena Cavaleiro; Rita Ribeiro-Oliveira; António Avelino; Tiago Antunes-Lopes; António Albino-Teixeira; Francisco Cruz; Paddy Dewan. "DU Is Induced by Low Levels of Urinary ATP in a Rat Model of Partial Bladder Outlet Obstruction: The Incidence of Both Events Decreases after Deobstruction". Advances in Urology 2022 (2022): 1-6. https://doi.org/10.1155/2022/6292457.
    10.1155/2022/6292457
  25. Mendes PA; Dias N; Simaes J; Dinis P; Cruz F; Pinto R. "Daily low dose of tadalafil improves pain and frequency in bladder pain syndrome/interstitial cystitis patients.". Turkish journal of urology (2022): http://europepmc.org/abstract/med/35118993.
    10.5152/tud.2022.21292
  26. Queissert, F.; Rourke, K.; Schönburg, S.; Giammò, A.; Gonsior, A.; González-enguita, C.; Romero, A.; et al. "ATOMS (Adjustable transobturator male system) is an effective and safe second-line treatment option for recurrent urinary incontinence after implantation of an advance/advance XP fixed male sling. a multicenter cohort analysis". Journal of Clinical Medicine 11 1 (2022): http://www.scopus.com/inward/record.url?eid=2-s2.0-85121581534&partnerID=MN8TOARS.
    10.3390/jcm11010081
  27. Abreu-Mendes, Pedro; Araújo-Silva, Beatriz; Charrua, Ana; Cruz, Francisco; Pinto, Rui. "Silodosin Improves Pain and Urinary Frequency in Bladder Pain Syndrome/Interstitial Cystitis Patients". Journal of clinical medicine (2022): https://europepmc.org/articles/PMC9571782.
    10.3390/jcm11195659
  28. Kreydin EI; Gomes CM; Cruz F. "Current pharmacotherapy of overactive bladder.". International braz j urol : official journal of the Brazilian Society of Urology (2021): http://europepmc.org/abstract/med/34003613.
    10.1590/s1677-5538.ibju.2021.99.12
  29. Nunez-Badinez P; De Leo B; Laux-Biehlmann A; Hoffmann A; Zollner TM; Saunders PTK; Simitsidellis I; et al. "Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: an Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain.". Pain (2021): http://europepmc.org/abstract/med/34448751.
    10.1097/j.pain.0000000000002248
  30. Angulo JC; Schönburg S; Giammò A; Queissert F; Gonsior A; González-Enguita C; Martins FE; Rourke K; Cruz F. "Artificial urinary sphincter or a second adjustable transobturator male system offer equivalent outcomes in patients whom required revision on the initial ATOMS device: An international multi-institutional experience.". Neurourology and urodynamics (2021): http://europepmc.org/abstract/med/33645867.
    10.1002/nau.24646
  31. Manso, M.; Pacheco-Figueiredo, L.; Antunes-Lopes, T.; Pina-Vaz, T.; Oliveira, G.; Cruz, F.; Dinis-Oliveira, P.; Silva, J.. "Kidney transplantation from donation after circulatory death using abdominal normothermic oxygenated circulation: are the outcomes equivalent?". International Urology and Nephrology 53 7 (2021): 1355-1359. http://www.scopus.com/inward/record.url?eid=2-s2.0-85102834428&partnerID=MN8TOARS.
    10.1007/s11255-021-02832-8
  32. Angulo, J.C.; Rourke, K.; Queissert, F.; Giammò, A.; Schönburg, S.; Cruz, F.; Martins, F.E.; Gonsior, A.; González-Enguita, C.. "Adjustable Transobturator Male System (ATOMS) Infection: Causative Organisms and Clinical Profile". Urology 157 (2021): 120-127. http://www.scopus.com/inward/record.url?eid=2-s2.0-85116498512&partnerID=MN8TOARS.
    10.1016/j.urology.2021.05.111
  33. Manso M; Botelho F; Silva C; Cruz F. "Mini-Slings: Do They Stand the Test of Time? A 10-Year Cohort.". Urologia internationalis (2020): http://europepmc.org/abstract/med/33264785.
    10.1159/000511648
  34. Cruz F. "Re: European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era.". European urology (2020): http://europepmc.org/abstract/med/33261939.
    10.1016/j.eururo.2020.11.030
  35. Abreu-Mendes P; Martins-Silva C; Antunes-Lopes T; Cruz F. "Treatment of Non-neurogenic Lower Urinary Tract Symptoms-A Review of Key Publications from 2018 Onward.". European urology focus (2020): http://europepmc.org/abstract/med/32624454.
    10.1016/j.euf.2020.06.015
  36. Abreu-Mendes P; Cruz F; Martins-Silva C. "Treatment of neurogenic lower urinary tract symptoms: main contributions from 2018 and 2019.". Current opinion in urology (2020): http://europepmc.org/abstract/med/32398466.
    10.1097/mou.0000000000000774
  37. Angulo JC; Virseda-Chamorro M; Arance I; Ruiz S; Ojea A; Carballo M; Rodríguez A; et al. "Long-term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study.". Neurourology and urodynamics (2020): http://europepmc.org/abstract/med/32496606.
    10.1002/nau.24410
  38. López-Fando L; Bueno P; Carracedo D; Averbeck M; Castro-Díaz DM; Chartier-Kastler E; Cruz F; et al. "Management of Female and Functional Urology Patients During the COVID Pandemic.". European urology focus (2020): http://europepmc.org/abstract/med/32540267.
    10.1016/j.euf.2020.05.023
  39. Cruz F. "Editorial Comment.". The Journal of urology (2020): http://europepmc.org/abstract/med/32436759.
    10.1097/ju.0000000000000807.01
  40. Abreu-Mendes P; Silva J; Cruz F. "Pharmacology of the lower urinary tract: update on LUTS treatment.". Therapeutic advances in urology (2020): http://europepmc.org/abstract/med/32489425.
    10.1177/1756287220922425
  41. Martín-Martínez, A.; Müller-Arteaga, C.; Blasco-Hernández, P.; Padilla-Fernández, B.; Martínez-García, R.; Errando-Smet, C.; Vicente-Palacio, E.; et al. "Position of Ibero-American Society of Neurourology and UroGynecology (SINUG) on the use of vaginal meshes in pelvic organ prolapse". Neurourology and Urodynamics 39 3 (2020): 1020-1025. http://www.scopus.com/inward/record.url?eid=2-s2.0-85079703864&partnerID=MN8TOARS.
    10.1002/nau.24309
  42. Müller-Arteaga C; Martín Martinez A; Padilla-Fernández B; Blasco Hernández P; Espuña Pons M; Cruz F; Errando-Smet C; Martínez-García R; Arlandis Guzmán S. "Position of the Ibero-American Society of Neurourology and Urogynecology in relation to the use of synthetic suburethral meshes for the surgical treatment of female stress incontinence.". Neurourology and urodynamics (2019): http://europepmc.org/abstract/med/31588610.
    10.1002/nau.24178
  43. Chapple CR; Cruz F; Cardozo L; Staskin D; Herschorn S; Choudhury N; Stoelzel M; Heesakkers J; Siddiqui E. "Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo.". European urology (2019): http://europepmc.org/abstract/med/31635815.
    10.1016/j.eururo.2019.09.024
  44. Dias B; Serrão P; Cruz F; Charrua A. "Effect of Water Avoidance Stress on serum and urinary NGF levels in rats: diagnostic and therapeutic implications for BPS/IC patients.". Scientific reports (2019): http://europepmc.org/abstract/med/31575913.
    10.1038/s41598-019-50576-4
  45. Charrua A; Matos R; Oliveira R; Marczylo T; Nagy I; Cruz F. "Fatty acid amide hydrolase inhibition normalises bladder function and reduces pain through normalising the anandamide/palmitoylethanolamine ratio in the inflamed bladder of rats.". Naunyn-Schmiedeberg's archives of pharmacology (2019): http://europepmc.org/abstract/med/31522241.
    10.1007/s00210-019-01729-9
  46. Oliveira R; Coelho A; Franquinho F; Sousa MM; Cruz F; D Cruz C. "Effects of early intravesical administration of resiniferatoxin to spinal cord-injured rats in neurogenic detrusor overactivity.". Neurourology and urodynamics (2019): http://europepmc.org/abstract/med/31180583.
    10.1002/nau.24032
  47. Coelho A; Charrua A; Oliveira R; Cavaleiro H; Cruz CD; Cruz F. "Underactive bladder in aging rats is associated with a reduced number of serotonin-expressing cells in the urethra and is improved by serotonin application to the urethra.". Lower urinary tract symptoms (2019): http://europepmc.org/abstract/med/31250566.
    10.1111/luts.12273
  48. Antunes-Lopes T; Cruz F. "Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019.". European urology focus (2019): http://europepmc.org/abstract/med/31231010.
    10.1016/j.euf.2019.06.006
  49. Vale L; Jesus F; Marcelissen T; Rieken M; Geavlete B; Rahnama'i MS; Martens F; et al. "Pathophysiological mechanisms in detrusor underactivity: Novel experimental findings.". Lower urinary tract symptoms (2019): http://europepmc.org/abstract/med/30864243.
    10.1111/luts.12257
  50. Angulo, J.C.; Arance, I.; Ojea, A.; Carballo, M.; Rodríguez, A.; Pereira, J.; Rebassa, M.; et al. "Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study". World Journal of Urology 37 10 (2019): 2189-2197. http://www.scopus.com/inward/record.url?eid=2-s2.0-85060154293&partnerID=MN8TOARS.
    10.1007/s00345-019-02639-4
  51. Angulo JC; Fonseca J; Esquinas C; Ojea A; Rodríguez A; Rabassa M; Teba F; Escribano G; Cruz F. "Adjustable transobturator male system (ATOMS®) as treatment of stress urinary incontinence secondary to transurethral resection of the prostate.". Actas urologicas espanolas (2018): http://europepmc.org/abstract/med/29929737.
    10.1016/j.acuro.2018.05.002
  52. Roncon-Albuquerque R; Gaião S; Figueiredo P; Príncipe N; Basílio C; Mergulhão P; Silva S; et al. "An integrated program of extracorporeal membrane oxygenation (ECMO) assisted cardiopulmonary resuscitation and uncontrolled donation after circulatory determination of death in refractory cardiac arrest.". Resuscitation (2018): http://europepmc.org/abstract/med/30321624.
    10.1016/j.resuscitation.2018.10.016
  53. Antunes-Lopes T; Vasconcelos A; Costa D; Charrua A; Neves J; Silva J; Cruz F; Silva C. "The Impact of Chronic Pelvic Ischemia on LUTS and Urinary Levels of Neuroinflammatory, Inflammatory, and Oxidative Stress Markers in Elderly Men: A Case-control Study.". Urology (2018): http://europepmc.org/abstract/med/30219559.
    10.1016/j.urology.2018.09.004
  54. Angulo JC; Esquinas C; Arance I; Rodríguez A; Pereira J; Rabassa M; Teyrouz A; et al. "Adjustable Transobturator Male System after Failed Surgical Devices for Male Stress Urinary Incontinence: A Feasibility Study.". Urologia internationalis (2018): http://europepmc.org/abstract/med/29953998.
    10.1159/000489316
  55. Nambiar AK; Bosch R; Cruz F; Lemack GE; Thiruchelvam N; Tubaro A; Bedretdinova DA; et al. "EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence.". European urology (2018): http://europepmc.org/abstract/med/29398262.
    10.1016/j.eururo.2017.12.031
  56. Coelho A; Oliveira R; Cavaleiro H; Cruz CD; Cruz F. "Evidence for an urethro-vesical crosstalk mediated by serotonin.". Neurourology and urodynamics (2018): http://europepmc.org/abstract/med/29664149.
    10.1002/nau.23590
  57. Angulo JC; Cruz F; Esquinas C; Arance I; Manso M; Rodríguez A; Pereira J; et al. "Treatment of male stress urinary incontinence with the adjustable transobturator male system: Outcomes of a multi-center Iberian study.". Neurourology and urodynamics (2018): http://europepmc.org/abstract/med/29315765.
    10.1002/nau.23474
  58. Kreydin, E.; Welk, B.; Chung, D.; Clemens, Q.; Yang, C.; Danforth, T.; Gousse, A.; et al. "Surveillance and management of urologic complications after spinal cord injury". World Journal of Urology 36 10 (2018): 1545-1553. http://www.scopus.com/inward/record.url?eid=2-s2.0-85047662147&partnerID=MN8TOARS.
    10.1007/s00345-018-2345-0
  59. Manso, M.; Pacheco-Figueiredo, L.; Santos-Silva, A.; Silva, J.; Silva, C.; Cruz, F.. "Renal cell carcinoma with venous thrombus: Should surgery be offered when metastasis is present at diagnosis?". Urologia Internationalis 101 4 (2018): 400-408. http://www.scopus.com/inward/record.url?eid=2-s2.0-85055246776&partnerID=MN8TOARS.
    10.1159/000493510
  60. Cruz, Francisco. "Intra-Trigonal Onabotulinum Toxin A improves bladder symptoms and quality of life in Bladder Pain Syndrome /Interstitial Cystitis patients - a pilot, single centre, randomized, double-blind, placebo-controlled trial.". The Journal of urology (2017): http://europepmc.org/abstract/med/29031769.
    10.1016/j.juro.2017.10.018
  61. Cruz, Francisco. "Expression of cleaved SNAP-25 after bladder wall injection of onabotulinumtoxina or abobotulinumtoxina: A comparative study in the mice.". Neurourology and urodynamics (2017): http://europepmc.org/abstract/med/26472491.
    10.1002/nau.22900
  62. Antunes-Lopes, T.; Coelho, A.; Pinto, R.; Barros, S.C.; Cruz, C.D.; Cruz, F.; Silva, C.M.. "Urinary Neurotrophin Levels Increase in Women With Stress Urinary Incontinence After a Midurethral Sling Procedure". Urology 99 (2017): 49-56. http://www.scopus.com/inward/record.url?eid=2-s2.0-85006248627&partnerID=MN8TOARS.
    10.1016/j.urology.2016.08.048
  63. Chapple, C.R.; Cruz, F.; Deffieux, X.; Milani, A.L.; Arlandis, S.; Artibani, W.; Bauer, R.M.; et al. "Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence". European Urology 72 3 (2017): 424-431. http://www.scopus.com/inward/record.url?eid=2-s2.0-85017455820&partnerID=MN8TOARS.
    10.1016/j.eururo.2017.03.048
  64. Antunes-Lopes, T.; Coelho, A.; Pinto, R.; Barros, S.C.; Cruz, C.D.; Cruz, F.; Silva, C.M.. "Author Reply". Urology 99 (2017): 55-56. http://www.scopus.com/inward/record.url?eid=2-s2.0-85006874618&partnerID=MN8TOARS.
    10.1016/j.urology.2016.08.050
  65. Matos, R.; Serrão, P.; Rodriguez, L.; Birder, L.A.; Cruz, F.; Charrua, A.. "The water avoidance stress induces bladder pain due to a prolonged alpha1A adrenoceptor stimulation". Naunyn-Schmiedeberg's Archives of Pharmacology 390 8 (2017): 839-844. http://www.scopus.com/inward/record.url?eid=2-s2.0-85020131502&partnerID=MN8TOARS.
    10.1007/s00210-017-1384-1
  66. Manso, M.; Alexandre, B.; Antunes-Lopes, T.; Martins-da-Silva, C.; Cruz, F.. "Is the adjustable transobturator system ATOMS® useful for the treatment of male urinary incontinence in low to medium volume urological centers? | Es útil el sistema transobturatriz ajustable ATOMS®para el tratamiento de la incontinencia urinaria masculina en centros urológicos de bajo y medio volumen?". Actas Urologicas Espanolas (2017): http://www.scopus.com/inward/record.url?eid=2-s2.0-85035054293&partnerID=MN8TOARS.
    10.1016/j.acuro.2017.07.011
  67. Roehrborn, C.G.; Cruz, F.; Fusco, F.. "a1-Blockers in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: Is Silodosin Different?". Advances in Therapy 33 12 (2017): 2110-2121. http://www.scopus.com/inward/record.url?eid=2-s2.0-84991669549&partnerID=MN8TOARS.
    10.1007/s12325-016-0423-5
  68. Kennelly, M.; Dmochowski, R.; Schulte-Baukloh, H.; Ethans, K.; Del Popolo, G.; Moore, C.; Jenkins, B.; et al. "Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study". Neurourology and Urodynamics 36 2 (2017): 368-375. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013791709&partnerID=MN8TOARS.
    10.1002/nau.22934
  69. Coelho, A.; Antunes-Lopes, T.; Gillespie, J.; Cruz, F.. "Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: An immunohistochemical study". Neurourology and Urodynamics 36 8 (2017): 1972-1980. http://www.scopus.com/inward/record.url?eid=2-s2.0-85012891631&partnerID=MN8TOARS.
    10.1002/nau.23224
  70. Cruz, Francisco. "Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.". Neuropharmacology (2016): http://europepmc.org/abstract/med/26965218.
    10.1016/j.neuropharm.2016.03.007
  71. Antunes-Lopes, T.; Martins da Silva, C.; Cruz, F.. "Evaluation of the Donor After Brain Death and Technique for Organ Procurement". European Urology, Supplements 15 9 (2016): 390-396. http://www.scopus.com/inward/record.url?eid=2-s2.0-84992200187&partnerID=MN8TOARS.
    10.1016/j.eursup.2016.08.004
  72. Martins-Silva, C.; Cruz, F.. "Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: Update of the Pivotal Randomised, Double-blind, Placebo-controlled Trials". European Urology Focus 2 3 (2016): 329-331. http://www.scopus.com/inward/record.url?eid=2-s2.0-84994718731&partnerID=MN8TOARS.
    10.1016/j.euf.2016.04.003
  73. Cruz, F.. "Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)". European Urology 70 5 (2016): http://www.scopus.com/inward/record.url?eid=2-s2.0-84994300338&partnerID=MN8TOARS.
    10.1016/j.eururo.2016.08.027
  74. Coelho, A.; Oliveira, R.; Cruz, F.; Cruz, C.D.. "Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats". Experimental Neurology 285 (2016): 159-166. http://www.scopus.com/inward/record.url?eid=2-s2.0-84971673771&partnerID=MN8TOARS.
    10.1016/j.expneurol.2016.05.029
  75. De Carvalho, T.G.R.; Pinto, R.; Cruz, F.; Silva, J.. "Effect of onabotulinum toxin type a intraprostatic injection on the outcome of benign prostatic hyperplasia patients refractory to medical therapy: A 2-year follow-up study". Archivos Espanoles de Urologia 69 10 (2016): 719-726. http://www.scopus.com/inward/record.url?eid=2-s2.0-85002322853&partnerID=MN8TOARS.
  76. Montorsi, F.; Gandaglia, G.; Chapple, C.; Cruz, F.; Desgrandchamps, F.; Llorente, C.. "Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study)". International Journal of Urology 23 7 (2016): 572-579. http://www.scopus.com/inward/record.url?eid=2-s2.0-84977602607&partnerID=MN8TOARS.
    10.1111/iju.13088
  77. Matos, R.; Cordeiro, J.M.; Coelho, A.; Ferreira, S.; Silva, C.; Igawa, Y.; Cruz, F.; Charrua, A.. "Bladder pain induced by prolonged peripheral alpha 1A adrenoceptor stimulation involves the enhancement of transient receptor potential vanilloid 1 activity and an increase of urothelial adenosine triphosphate release". Acta Physiologica 218 4 (2016): 265-275. http://www.scopus.com/inward/record.url?eid=2-s2.0-84978758937&partnerID=MN8TOARS.
    10.1111/apha.12744
  78. Cruz F. "Transient receptor potential channel: a reality that still requires many years of scientific efforts.". (2015): http://europepmc.org/abstract/med/25885558.
    10.1111/bju.12944
  79. Dinis, S.; de Oliveira, J.T.; Pinto, R.; Cruz, F.; Buffington, C.A.T.; Dinis, P.. "From bladder to systemic syndrome: Concept and treatment evolution of interstitial cystitis". International Journal of Women's Health 7 (2015): 735-744. http://www.scopus.com/inward/record.url?eid=2-s2.0-84938075457&partnerID=MN8TOARS.
    10.2147/IJWH.S60798
  80. Frias, B.; Santos, J.; Morgado, M.; Sousa, M.M.; Gray, S.M.; McCloskey, K.D.; Allen, S.; Cruz, F.; Cruz, C.D.. "The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO)". Journal of Neuroscience 35 5 (2015): 2146-2160. http://www.scopus.com/inward/record.url?eid=2-s2.0-84922372549&partnerID=MN8TOARS.
    10.1523/JNEUROSCI.0373-14.2015
  81. Laterza, R.M.; Sievert, K.-D.; De Ridder, D.; Vierhout, M.E.; Haab, F.; Cardozo, L.; Van Kerrebroeck, P.; et al. "Bladder function after radical hysterectomy for cervical cancer". Neurourology and Urodynamics 34 4 (2015): 309-315. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927005857&partnerID=MN8TOARS.
    10.1002/nau.22570
  82. Camoes, J.; Coelho, A.; Castro-Diaz, D.; Cruz, F.. "Lower Urinary Tract Symptoms and Aging: The Impact of Chronic Bladder Ischemia on Overactive Bladder Syndrome". Urologia Internationalis 95 4 (2015): 373-379. http://www.scopus.com/inward/record.url?eid=2-s2.0-84983133244&partnerID=MN8TOARS.
    10.1159/000437336
  83. Cruz, C.D.; Coelho, A.; Antunes-Lopes, T.; Cruz, F.. "Biomarkers of spinal cord injury and ensuing bladder dysfunction". Advanced Drug Delivery Reviews 82 (2015): 153-159. http://www.scopus.com/inward/record.url?eid=2-s2.0-84927129630&partnerID=MN8TOARS.
    10.1016/j.addr.2014.11.007
  84. Thiruchelvam, N.; Cruz, F.; Kirby, M.; Tubaro, A.; Chapple, C.R.; Sievert, K.-D.. "A review of detrusor overactivity and the overactive bladder after radical prostate cancer treatment". BJU International 116 6 (2015): 853-861. http://www.scopus.com/inward/record.url?eid=2-s2.0-84946212818&partnerID=MN8TOARS.
    10.1111/bju.13078
  85. Bunn, F.; Kirby, M.; Pinkney, E.; Cardozo, L.; Chapple, C.; Chester, K.; Cruz, F.; et al. "Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies". International Journal of Clinical Practice 69 2 (2015): 199-217. http://www.scopus.com/inward/record.url?eid=2-s2.0-84921857785&partnerID=MN8TOARS.
    10.1111/ijcp.12518
  86. Cruz FM; Munhoz BA; Alves BC; Gehrke FS; Fonseca F; Kuniyoshi RK; Cubero D; Peppone LJ; Del Giglio A. "Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression.". (2015): http://europepmc.org/abstract/med/25852820.
    10.1186/s40169-015-0051-8
  87. Cruz, F.. "Re: Combination treatment with mirabegron and solifenacin in patients with overactive bladder: Efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (symphony)". European Urology 67 6 (2015): 1189-1190. http://www.scopus.com/inward/record.url?eid=2-s2.0-84930007471&partnerID=MN8TOARS.
    10.1016/j.eururo.2015.02.017
  88. Coelho, A.; Wolf-Johnston, A.S.; Shinde, S.; Cruz, C.D.; Cruz, F.; Avelino, A.; Birder, L.A.. "Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels". British Journal of Pharmacology 172 7 (2015): 1691-1699. http://www.scopus.com/inward/record.url?eid=2-s2.0-84924916268&partnerID=MN8TOARS.
    10.1111/bph.12958
  89. Martins Da Silva, C.; Chancellor, M.B.; Smith, C.P.; Cruz, F.. "Use of botulinum toxin for genitourinary conditions: What is the evidence?". Toxicon 107 (2015): 141-147. http://www.scopus.com/inward/record.url?eid=2-s2.0-84947869452&partnerID=MN8TOARS.
    10.1016/j.toxicon.2015.07.333
  90. Charrua, A.; Cruz, C.D.; Jansen, D.; Rozenberg, B.; Heesakkers, J.; Cruz, F.. "Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis". BJU International 115 3 (2015): 452-460. http://www.scopus.com/inward/record.url?eid=2-s2.0-84922965308&partnerID=MN8TOARS.
    10.1111/bju.12861
  91. Charrua, A.; Pinto, R.; Birder, L.A.; Cruz, F.. "Sympathetic nervous system and chronic bladder pain: A new tune for an old song". Translational Andrology and Urology 4 5 (2015): 534-542. http://www.scopus.com/inward/record.url?eid=2-s2.0-84946849026&partnerID=MN8TOARS.
    10.3978/j.issn.2223-4683.2015.09.06
  92. Coelho A; Oliveira R; Rossetto O; Cruz CD; Cruz F; Avelino A. "Intrathecal administration of botulinum toxin type A improves urinary bladder function and reduces pain in rats with cystitis.". (2014): http://europepmc.org/abstract/med/24756904.
    10.1002/ejp.513
  93. Silva, J.; Silva, C.M.; Cruz, F.. "Current medical treatment of lower urinary tract symptoms/BPH: Do we have a standard?". Current Opinion in Urology 24 1 (2014): 21-28. http://www.scopus.com/inward/record.url?eid=2-s2.0-84889882636&partnerID=MN8TOARS.
    10.1097/MOU.0000000000000007
  94. Pinto, R.; Lopes, T.; Costa, D.; Barros, S.; Silva, J.; Silva, C.; Cruz, C.; Dinis, P.; Cruz, F.. "Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin a". Urology 83 5 (2014): 1030-1034. http://www.scopus.com/inward/record.url?eid=2-s2.0-84899096668&partnerID=MN8TOARS.
    10.1016/j.urology.2014.01.018
  95. Araújo, J.R.; Silva, S.E.; Cruz, F.; Falcão-Reis, F.. "Acute transient myopia with shallowing of the anterior chamber induced by sulfamethoxazole in a patient with pseudoxanthoma elasticum". Journal of Glaucoma 23 6 (2014): 415-417. http://www.scopus.com/inward/record.url?eid=2-s2.0-84905437534&partnerID=MN8TOARS.
    10.1097/IJG.0000000000000074
  96. Ginsberg, D.; Cruz, F.; Herschorn, S.; Gousse, A.; Keppenne, V.; Aliotta, P.; Sievert, K.-D.; et al. "Erratum to: OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of concomitant anticholinergic use or neurologic etiology (Advances in Therapy (2013) 30, (819-833) DOI:10.1007/s12325-013-0054-z)". Advances in Therapy 31 2 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84899098561&partnerID=MN8TOARS.
    10.1007/s12325-014-0103-2
  97. Eisenhardt, A.; Schneider, T.; Cruz, F.; Oelke, M.. "Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies". World Journal of Urology 32 5 (2014): 1119-1125. http://www.scopus.com/inward/record.url?eid=2-s2.0-84892421141&partnerID=MN8TOARS.
    10.1007/s00345-013-1228-7
  98. Cruz, F.; Nitti, V.. "Chapter 5: Clinical data in neurogenic detrusor overactivity (NDO) and overactive bladder (OAB)". Neurourology and Urodynamics 33 SUPPL.3 (2014): http://www.scopus.com/inward/record.url?eid=2-s2.0-84904811738&partnerID=MN8TOARS.
    10.1002/nau.22630
  99. Antunes-Lopes, T.; Pinto, R.; Morgado, P.; Madaleno, P.; Silva, J.; Silva, C.; Cruz, F.. "Intrarenal artery pseudoaneurysm after blunt abdominal trauma: A case report of successful superselective angioembolization". Research and Reports in Urology 6 1 (2014): 17-20. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897937407&partnerID=MN8TOARS.
    10.2147/RRU.S58291
  100. Cruz, F.. "Targets for botulinum toxin in the lower urinary tract". Neurourology and Urodynamics 33 1 (2014): 31-38. http://www.scopus.com/inward/record.url?eid=2-s2.0-84890312596&partnerID=MN8TOARS.
    10.1002/nau.22445
  101. Karsenty, G.; Baverstock, R.; Carlson, K.; Diaz, D.C.; Cruz, F.; Dmochowski, R.; Fulford, S.; et al. "Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: Reviewing the procedure". International Journal of Clinical Practice 68 6 (2014): 731-742. http://www.scopus.com/inward/record.url?eid=2-s2.0-84901200922&partnerID=MN8TOARS.
    10.1111/ijcp.12360
  102. Rui Oliveira; Alexandre Resende; Carlos Silva; Paulo Dinis; Francisco Cruz. "Mini-Arc for the Treatment of Female Stress Urinary Incontinence: Long-Term Prospective Evaluation by Patient Reported Outcomes". ISRN Urology 2014 (2014): 1-4. http://dx.doi.org/10.1155/2014/659383.
    10.1155/2014/659383
  103. Ginsberg D; Cruz F; Herschorn S; Gousse A; Keppenne V; Aliotta P; Sievert K; et al. "Erratum to: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology.". (2014): http://europepmc.org/abstract/PMC/PMC4079522.
  104. Pina, F.; Botelho, F.; Lopes, T.; Lopes, I.; Figueiredo, G.; Portugal, R.; Ferro, A.; et al. "Can serum angiogenin be used to improve the diagnostic performance in prostate cancer screening?". European Journal of Cancer Prevention 23 3 (2014): 166-172. http://www.scopus.com/inward/record.url?eid=2-s2.0-84897452099&partnerID=MN8TOARS.
    10.1097/CEJ.0b013e3283647453
  105. Antunes-Lopes, T.; Cruz, C.D.; Cruz, F.; Sievert, K.D.. "Biomarkers in lower urinary tract symptoms/overactive bladder: A critical overview". Current Opinion in Urology 24 4 (2014): 352-357. http://www.scopus.com/inward/record.url?eid=2-s2.0-84902288461&partnerID=MN8TOARS.
    10.1097/MOU.0000000000000064
  106. Charrua A; Pinto R; Taylor A; Canelas A; Ribeiro-da-Silva A; Cruz CD; Birder LA; et al. "Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study.". Neurourol. Urodynam. (2013): n/a-n/a. http://europepmc.org/abstract/med/24375689.
    10.1002/nau.22542
  107. Lucas, M.G.; Bosch, R.J.L.; Burkhard, F.C.; Cruz, F.; Madden, T.B.; Nambiar, A.K.; Neisius, A.; et al. "European association of urology guidelines on assessment and nonsurgical management of urinary incontinence | Guía clínica de la Asociación Europea de Urología sobre la evaluación y el tratamiento no quirúrgico de la incontinencia urinaria". Actas Urologicas Espanolas 37 4 (2013): 199-213. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875738106&partnerID=MN8TOARS.
    10.1016/j.acuro.2012.12.001
  108. Soler, R.; Andersson, K.-E.; Chancellor, M.B.; Chapple, C.R.; De Groat, W.C.; Drake, M.J.; Gratzke, C.; Lee, R.; Cruz, F.. "Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms". European Urology 64 4 (2013): 610-621. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883764805&partnerID=MN8TOARS.
    10.1016/j.eururo.2013.04.042
  109. Lucas, M.G.; Bosch, R.J.L.; Burkhard, F.C.; Cruz, F.; Madden, T.B.; Nambiar, A.K.; Neisius, A.; et al. "EAU guidelines on surgical treatment of urinary incontinence | Guía clínica de la Asociación Europea de Urología sobre el tratamiento quirúrgico de la incontinencia urinaria". Actas Urologicas Espanolas 37 8 (2013): 459-472. http://www.scopus.com/inward/record.url?eid=2-s2.0-84882909925&partnerID=MN8TOARS.
    10.1016/j.acuro.2013.02.002
  110. Avelino, A.; Charrua, A.; Frias, B.; Cruz, C.; Boudes, M.; de Ridder, D.; Cruz, F.. "Transient receptor potential channels in bladder function". Acta Physiologica 207 1 (2013): 110-122. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870769243&partnerID=MN8TOARS.
    10.1111/apha.12021
  111. Lucas, M.G.; Bosch, R.J.L.; Burkhard, F.C.; Cruz, F.; Madden, T.B.; Nambiar, A.K.; Neisius, A.; et al. "Erratum: EAU guidelines on assessment and nonsurgical management of urinary incontinence (European Urology (2012) 62 (1130-42))". European Urology 64 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84878833294&partnerID=MN8TOARS.
    10.1016/j.eururo.2013.02.033
  112. Antunes-Lopes, T.; Pinto, R.; Barros, S.C.; Botelho, F.; Silva, C.M.; Cruz, C.D.; Cruz, F.. "Urinary neurotrophic factors in healthy individuals and patients with overactive bladder". Journal of Urology 189 1 (2013): 359-365. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870862035&partnerID=MN8TOARS.
    10.1016/j.juro.2012.08.187
  113. Santos-Silva, A.; da Silva, C.M.; Cruz, F.. "Botulinum toxin treatment for bladder dysfunction". International Journal of Urology 20 10 (2013): 956-962. http://www.scopus.com/inward/record.url?eid=2-s2.0-84884983332&partnerID=MN8TOARS.
    10.1111/iju.12188
  114. Pinto, R.; Lopes, T.; Silva, J.; Silva, C.; Dinis, P.; Cruz, F.. "Persistent therapeutic effect of repeated injections of onabotulinum toxin A in refractory bladder pain syndrome/interstitial cystitis". Journal of Urology 189 2 (2013): 548-553. http://www.scopus.com/inward/record.url?eid=2-s2.0-84872132532&partnerID=MN8TOARS.
    10.1016/j.juro.2012.09.027
  115. Ginsberg, D.; Cruz, F.; Herschorn, S.; Gousse, A.; Keppenne, V.; Aliotta, P.; Sievert, K.-D.; et al. "Onabotulinumtoxina is effective in patients with urinary incontinence due to neurogenic detrusor activity regardless of concomitant anticholinergic use or neurologic etiology". Advances in Therapy 30 9 (2013): 819-833. http://www.scopus.com/inward/record.url?eid=2-s2.0-84894345269&partnerID=MN8TOARS.
    10.1007/s12325-013-0054-z
  116. Magno-Azevedo, V.; Silva, C.; Cruz, F.. "Single Incision Slings: Is There a Role?". Current Bladder Dysfunction Reports 8 1 (2013): 19-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873660622&partnerID=MN8TOARS.
    10.1007/s11884-012-0165-4
  117. Tomada, N.; Tomada, I.; Botelho, F.; Pacheco-Figueiredo, L.; Lopes, T.; Negrão, R.; Pestana, M.; Cruz, F.. "Endothelial function in patients with metabolic syndrome and erectile dysfunction: A question of Angiopoietin imbalance?". Andrology 1 4 (2013): 541-548. http://www.scopus.com/inward/record.url?eid=2-s2.0-84879467763&partnerID=MN8TOARS.
    10.1111/j.2047-2927.2013.00102.x
  118. Diniz, S.; Dinis, P.; Cruz, F.; Pinto, R.. "Bladder pain syndrome/interstitial cystitis: Present and future treatment perspectives". Minerva Urologica e Nefrologica 65 4 (2013): 263-276. http://www.scopus.com/inward/record.url?eid=2-s2.0-84891393566&partnerID=MN8TOARS.
  119. Frias, B.; Allen, S.; Dawbarn, D.; Charrua, A.; Cruz, F.; Cruz, C.D.. "Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation". Neuroscience 234 (2013): 88-102. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873488462&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2012.12.044
  120. Botelho, F.; Pina, F.; Figueiredo, L.; Cruz, F.; Lunet, N.. "Does baseline total testosterone improve the yielding of prostate cancer screening?". European Journal of Cancer 48 11 (2012): 1657-1663. http://www.scopus.com/inward/record.url?eid=2-s2.0-84862756352&partnerID=MN8TOARS.
    10.1016/j.ejca.2012.01.025
  121. Santos-Silva, A.; Charrua, A.; Cruz, C.D.; Gharat, L.; Avelino, A.; Cruz, F.. "Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist". Autonomic Neuroscience: Basic and Clinical 166 1-2 (2012): 35-38. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855942949&partnerID=MN8TOARS.
    10.1016/j.autneu.2011.09.005
  122. Cruz, F.. "The future of pharmacologic treatment for bladder pain syndrome/ interstitial cystitis: Lessons from a meta-analysis". European Urology 61 1 (2012): 54-55. http://www.scopus.com/inward/record.url?eid=2-s2.0-82255179421&partnerID=MN8TOARS.
    10.1016/j.eururo.2011.09.015
  123. Ochodnicky, P.; Cruz, C.D.; Yoshimura, N.; Cruz, F.. "Neurotrophins as regulators of urinary bladder function". Nature Reviews Urology 9 11 (2012): 628-637. http://www.scopus.com/inward/record.url?eid=2-s2.0-84869089923&partnerID=MN8TOARS.
    10.1038/nrurol.2012.178
  124. Lucas, M.G.; Bosch, R.J.L.; Burkhard, F.C.; Cruz, F.; Madden, T.B.; Nambiar, A.K.; Neisius, A.; et al. "EAU guidelines on surgical treatment of urinary incontinence". European Urology 62 6 (2012): 1118-1129. http://www.scopus.com/inward/record.url?eid=2-s2.0-84868534860&partnerID=MN8TOARS.
    10.1016/j.eururo.2012.09.023
  125. Coelho, A.; Cruz, F.; Cruz, C.D.; Avelino, A.. "Effect of onabotulinumtoxin-A on intramural parasympathetic ganglia: An experimental study in the guinea pig bladder". Journal of Urology 187 3 (2012): 1121-1126. http://www.scopus.com/inward/record.url?eid=2-s2.0-84857042208&partnerID=MN8TOARS.
    10.1016/j.juro.2011.10.130
  126. Coelho, A.; Cruz, F.; Cruz, C.D.; Avelino, A.. "Reply from Authors re: Prokar Dasgupta. Volume matters: Bladder injections of botulinum toxin type A. Eur Urol 2012;61:1185-6: Yes, Volume matters: Bladder injections of botulinum toxin type A". European Urology 61 6 (2012): 1186-1187. http://www.scopus.com/inward/record.url?eid=2-s2.0-84860310373&partnerID=MN8TOARS.
    10.1016/j.eururo.2012.03.009
  127. Cruz, F.; Tubaro, A.. "Future assessments of overactive bladder". European Urological Review 7 1 (2012): 36-41. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871836613&partnerID=MN8TOARS.
  128. Drake, M.J.; Cruz, F.M.J.. "Lower urinary tract management in patients with neurological disease". UroToday International Journal 5 1 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84856565635&partnerID=MN8TOARS.
  129. Frias, B.; Charrua, A.; Avelino, A.; Michel, M.C.; Cruz, F.; Cruz, C.D.; Frias B; et al. "Transient receptor potential vanilloid 1 mediates nerve growth factor-induced bladder hyperactivity and noxious input.". BJU international 110 8 Pt B (2012): E422-E428. http://www.scopus.com/inward/record.url?eid=2-s2.0-85027938481&partnerID=MN8TOARS.
    10.1111/j.1464-410X.2012.11187.x
  130. Gorgal, T.; Charrua, A.; Silva, J.F.; Avelino, A.; Dinis, P.; Cruz, F.. "Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type a injection". BMC Urology 12 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84855257664&partnerID=MN8TOARS.
    10.1186/1471-2490-12-1
  131. Osman, N.I.; Chapple, C.R.; Cruz, F.; Desgrandchamps, F.; Llorente, C.; Montorsi, F.. "Silodosin: A new subtype selective alpha-1 antagonist for the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia". Expert Opinion on Pharmacotherapy 13 14 (2012): 2085-2096. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866235207&partnerID=MN8TOARS.
    10.1517/14656566.2012.714368
  132. Coelho, A.; Cruz, F.; Cruz, C.D.; Avelino, A.. "Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action". European Urology 61 6 (2012): 1178-1184. http://www.scopus.com/inward/record.url?eid=2-s2.0-84860271852&partnerID=MN8TOARS.
    10.1016/j.eururo.2012.01.046
  133. Arenas Da Silva, L.F.; Schönthaler, M.; Cruz, F.; Gratzke, C.; Zumbe, J.; Stenzl, A.; Amend, B.; Sievert, K.-D.. "New treatment strategies for male lower urinary tract symptoms | Neue Behandlungskonzepte von Symptomen des unteren Harntraktes beim Mann". Urologe - Ausgabe A 51 12 (2012): 1697-1702. http://www.scopus.com/inward/record.url?eid=2-s2.0-84874498525&partnerID=MN8TOARS.
    10.1007/s00120-012-3032-1
  134. Lucas, M.G.; Bosch, R.J.L.; Burkhard, F.C.; Cruz, F.; Madden, T.B.; Nambiar, A.K.; Neisius, A.; et al. "EAU guidelines on assessment and nonsurgical management of urinary incontinence". European Urology 62 6 (2012): 1130-1142. http://www.scopus.com/inward/record.url?eid=2-s2.0-84868559568&partnerID=MN8TOARS.
    10.1016/j.eururo.2012.08.047
  135. Cruz, Francisco. "817 URINARY NEUROTROPHIC FACTORS IN BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS". (2012):
    10.1016/j.juro.2012.02.907
  136. Frias B; Lopes T; Pinto R; Cruz F; Cruz CD. "Neurotrophins in the lower urinary tract: becoming of age.". (2011): http://europepmc.org/abstract/med/22654715.
    10.2174/157015911798376253
  137. Saban, M.R.; Davis, C.A.; Avelino, A.; Cruz, F.; Maier, J.; Bjorling, D.E.; Sferra, T.J.; Hurst, R.E.; Saban, R.. "VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG". BMC Physiology 11 1 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-80355131520&partnerID=MN8TOARS.
    10.1186/1472-6793-11-16
  138. Oliveira, R.; Botelho, F.; Silva, P.; Resende, A.; Silva, C.; Dinis, P.; Cruz, F.. "Single-incision sling system as primary treatment of female stress urinary incontinence: Prospective 12 months data from a single institution". BJU International 108 10 (2011): 1616-1621. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955609737&partnerID=MN8TOARS.
    10.1111/j.1464-410X.2011.10158.x
  139. Oliveira, R.; Botelho, F.; Silva, P.; Resende, A.; Silva, C.; Dinis, P.; Cruz, F.. "Reply from authors re: Elisabetta costantini and massimo lazzeri. Surgery for stress urinary incontinence: So near and yet so far. Eur Urol 2011;59:945-6". European Urology 59 6 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-79955603384&partnerID=MN8TOARS.
    10.1016/j.eururo.2011.02.021
  140. Antunes-Lopes, T.; Carvalho-Barros, S.; Cruz, C.-D.; Cruz, F.; Martins-Silva, C.. "Biomarkers in overactive bladder: A new objective and noninvasive tool?". Advances in Urology (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-80052663719&partnerID=MN8TOARS.
    10.1155/2011/382431
  141. Tomada, N.; Tomada, I.; Botelho, F.; Cruz, F.; Vendeira, P.. "Are all metabolic syndrome components responsible for penile hemodynamics impairment in patients with erectile dysfunction? The role of body fat mass assessment". Journal of Sexual Medicine 8 3 (2011): 831-839. http://www.scopus.com/inward/record.url?eid=2-s2.0-79952030945&partnerID=MN8TOARS.
    10.1111/j.1743-6109.2010.02122.x
  142. Athanasopoulos, A.; Cruz, F.. "The medical treatment of overactive bladder, including current and future treatments". Expert Opinion on Pharmacotherapy 12 7 (2011): 1041-1055. http://www.scopus.com/inward/record.url?eid=2-s2.0-79953837756&partnerID=MN8TOARS.
    10.1517/14656566.2011.554399
  143. Silva, J.; Pinto, R.; Carvalho, T.; Botelho, F.; Silva, P.; Silva, C.; Cruz, F.; Dinis, P.. "Intraprostatic botulinum toxin type A administration: Evaluation of the effects on sexual function". BJU International 107 12 (2011): 1950-1954. http://www.scopus.com/inward/record.url?eid=2-s2.0-79957838885&partnerID=MN8TOARS.
    10.1111/j.1464-410X.2010.09841.x
  144. Oliveira, R.; Silva, C.; Dinis, P.; Cruz, F.; Oliveira R; Silva C; Dinis P; Cruz F. "Suburethral single incision slings in the treatment of female stress urinary incontinence: What is the evidence for using them in 2010?". Archivos Espanoles de Urologia 64 4 (2011): 339-346. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955916770&partnerID=MN8TOARS.
  145. Cruz, C.D.; Cruz, F.. "Spinal cord injury and bladder dysfunction: New ideas about an old problem". TheScientificWorldJournal 11 (2011): 214-234. http://www.scopus.com/inward/record.url?eid=2-s2.0-79551472987&partnerID=MN8TOARS.
    10.1100/tsw.2011.26
  146. Cruz, Francisco. "1952 URINARY NEUROTROPHINS – POTENTIAL BIOMARKERS OF OVERACTIVE BLADDER". (2011):
    10.1016/j.juro.2011.02.2156
  147. Cruz, F.; Herschorn, S.; Aliotta, P.; Brin, M.; Thompson, C.; Lam, W.; Daniell, G.; Heesakkers, J.; Haag-Molkenteller, C.. "Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: A randomised, double-blind, placebo-controlled trial". European Urology 60 4 (2011): 742-750. http://www.scopus.com/inward/record.url?eid=2-s2.0-80052268776&partnerID=MN8TOARS.
    10.1016/j.eururo.2011.07.002
  148. Heesakkers, J.P.F.A.; Cruz, F.; Igawa, Y.; Kocjancic, E.. "Overactive bladder: Pathophysiology, diagnostics, and therapies". Advances in Urology (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-84863696511&partnerID=MN8TOARS.
    10.1155/2011/863504
  149. Oliveira, R.; Botelho, F.; Silva, P.; Resende, A.; Silva, C.; Dinis, P.; Cruz, F.. "Exploratory study assessing efficacy and complications of TVT-O, TVT-Secur, and Mini-Arc: Results at 12-month follow-up". European Urology 59 6 (2011): 940-944. http://www.scopus.com/inward/record.url?eid=2-s2.0-79955590346&partnerID=MN8TOARS.
    10.1016/j.eururo.2011.01.018
  150. Pinto, R.; Frias, B.; Allen, S.; Dawbarn, D.; McMahon, S.B.; Cruz, F.; Cruz, C.D.. "Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2reduces bladder overactivity and noxious input in animals with chronic cystitis". Neuroscience 166 3 (2010): 907-916. http://www.scopus.com/inward/record.url?eid=2-s2.0-77549086946&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2010.01.015
  151. Botelho, F.; Pina, F.; Silva, P.; Figueiredo, G.; Cruz, F.; Lunet, N.. "Vascular endothelial growth factor (VEGF) and prostate pathology". International Braz J Urol 36 4 (2010): 430-437. http://www.scopus.com/inward/record.url?eid=2-s2.0-77955279574&partnerID=MN8TOARS.
    10.1590/S1677-55382010000400006
  152. Charrua, A.; Avelino, A.; Silva, A.; Cruz, F.. "TRPV1 in GU disorders". Open Drug Discovery Journal 2 SPEC. ISS. (2010): 50-54. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863952961&partnerID=MN8TOARS.
    10.2174/1877381801002030050
  153. Coelho, A.; Dinis, P.; Pinto, R.; Gorgal, T.; Silva, C.; Silva, A.; Silva, J.; et al. "Distribution of the High-Affinity Binding Site and Intracellular Target of Botulinum Toxin Type A in the Human Bladder". European Urology 57 5 (2010): 884-890. http://www.scopus.com/inward/record.url?eid=2-s2.0-77949654631&partnerID=MN8TOARS.
    10.1016/j.eururo.2009.12.022
  154. Coelho, Ana; Cruz, Francisco; D. Cruz, Celia; Avelino, Antonio. "191 EFFECT OF BOTULINUM TOXIN TYPE A ON INTRAMURAL PARASYMPATHETIC GANGLIA OF THE GUINEA-PIG BLADDER". The Journal of Urology 183 4 (2010): e76-e76. http://dx.doi.org/10.1016/j.juro.2010.02.247.
    10.1016/j.juro.2010.02.247
  155. Pinto, R.; Lopes, T.; Frias, B.; Silva, A.; Silva, J.A.; Silva, C.M.; Cruz, C.; Cruz, F.; Dinis, P.. "Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis". European Urology 58 3 (2010): 360-365. http://www.scopus.com/inward/record.url?eid=2-s2.0-77955512471&partnerID=MN8TOARS.
    10.1016/j.eururo.2010.02.031
  156. Cruz, F.; Desgrandchamps, F.. "New Concepts and Pathophysiology of Lower Urinary Tract Symptoms in Men". European Urology, Supplements 9 4 (2010): 472-476. http://www.scopus.com/inward/record.url?eid=2-s2.0-77952878477&partnerID=MN8TOARS.
    10.1016/j.eursup.2010.04.003
  157. Birder, L.A.; Kanai, A.J.; Cruz, F.; Moore, K.; Fry, C.H.. "Is the urothelium intelligent?". Neurourology and Urodynamics 29 4 (2010): 598-602. http://www.scopus.com/inward/record.url?eid=2-s2.0-77953547309&partnerID=MN8TOARS.
    10.1002/nau.20914
  158. Tomada, N.; Tomada, I.; Cruz, F.; Vendeira, P.; Neves, D.. "Characterization of VEGF and angiopoietins expression in human corpus cavernosum during aging". Journal of Sexual Medicine 7 4 PART 1 (2010): 1410-1418. http://www.scopus.com/inward/record.url?eid=2-s2.0-77955233814&partnerID=MN8TOARS.
    10.1111/j.1743-6109.2009.01648.x
  159. Silva J; Pinto R; Carvallho T; Coelho A; Avelino A; Dinis P; Cruz F. "Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.". (2009): http://europepmc.org/abstract/med/18649990.
    10.1016/j.eururo.2008.07.003
  160. da Silva CM; Cruz F. "Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?". (2009): http://europepmc.org/abstract/med/19444121.
    10.1097/MOU.0b013e32832ae176
  161. Silva J; Pinto R; Carvalho T; Botelho F; Silva P; Oliveira R; Silva C; Cruz F; Dinis P. "Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment.". (2009): http://europepmc.org/abstract/med/19682392.
    10.1186/1471-2490-9-9
  162. Botelho, F.; Pinho, L.; Silva, C.; Paquete, J.; Cruz, F.. "Kidney hemorrhage after renal biopsy treated by percutaneous superselective segmental renal artery embolization". UroToday International Journal 2 5 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-70350330304&partnerID=MN8TOARS.
    10.3834/uij.1944-5784.2009.10.10
  163. Ferreira, S.G.; Lomaglio, T.; Avelino, A.; Cruz, F.; Oliveira, C.R.; Cunha, R.A.; Köfalvi, A.. "N-acyldopamines control striatal input terminals via novel ligand-gated cation channels". Neuropharmacology 56 3 (2009): 676-683. http://www.scopus.com/inward/record.url?eid=2-s2.0-58749097218&partnerID=MN8TOARS.
    10.1016/j.neuropharm.2008.12.001
  164. Charrua, A.; Cruz, C.D.; Narayanan, S.; Gharat, L.; Gullapalli, S.; Cruz, F.; Avelino, A.. "GRC-6211, a New Oral Specific TRPV1 Antagonist, Decreases Bladder Overactivity and Noxious Bladder Input in Cystitis Animal Models". Journal of Urology 181 1 (2009): 379-386. http://www.scopus.com/inward/record.url?eid=2-s2.0-57149095621&partnerID=MN8TOARS.
    10.1016/j.juro.2008.08.121
  165. Cruz, F.; Dambros, M.; Naber, K.G.; Bauer, H.W.; Cozma, G.. "Recurrent Urinary Tract Infections: Uro-Vaxom®, a New Alternative". European Urology, Supplements 8 9 (2009): 762-768. http://www.scopus.com/inward/record.url?eid=2-s2.0-68949172258&partnerID=MN8TOARS.
    10.1016/j.eursup.2009.07.002
  166. Ramon, J.; Cruz, F.; Schulman, C.C.. "Controversies in Urology (CURy): What Is It All About?". European Urology, Supplements 8 9 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-68949175356&partnerID=MN8TOARS.
    10.1016/j.eursup.2009.07.004
  167. Guimarães, M.; Oliveira, R.; Pinto, R.; Soares, A.; Maia, E.; Botelho, F.; Sousa, T.; et al. "Intermediate-term results, up to 4 years, of a bone-anchored male perineal sling for treating male stress urinary incontinence after prostate surgery". BJU International 103 4 (2009): 500-504. http://www.scopus.com/inward/record.url?eid=2-s2.0-59249090851&partnerID=MN8TOARS.
    10.1111/j.1464-410X.2008.08067.x
  168. Andersson, K.-E.; Chapple, C.R.; Cardozo, L.; Cruz, F.; Hashim, H.; Michel, M.C.; Tannenbaum, C.; Wein, A.J.. "Pharmacological treatment of overactive bladder: Report from the International Consultation on Incontinence". Current Opinion in Urology 19 4 (2009): 380-394. http://www.scopus.com/inward/record.url?eid=2-s2.0-68249084476&partnerID=MN8TOARS.
    10.1097/MOU.0b013e32832ce8a4
  169. Charrua, A.; Reguenga, C.; Cordeiro, J.M.; Correiade-Sá, P.; Paule, C.; Nagy, I.; Cruz, F.; Avelino, A.. "Functional Transient Receptor Potential Vanilloid 1 is Expressed in Human Urothelial Cells". Journal of Urology 182 6 (2009): 2944-2950. http://www.scopus.com/inward/record.url?eid=2-s2.0-71849109253&partnerID=MN8TOARS.
    10.1016/j.juro.2009.08.022
  170. Cruz, F.; Heesakkers, J.; Khullar, V.; Tubaro, A.. "Bladder Wall Thickness in Overactive Bladder: Does It Have a Role?". European Urology, Supplements 8 9 (2009): 769-771. http://www.scopus.com/inward/record.url?eid=2-s2.0-68949180209&partnerID=MN8TOARS.
    10.1016/j.eursup.2009.05.002
  171. Cruz, F.; Silva, J.; Pinto, R.; Carvallho, T.; Coelho, A.; Avelino, A.; Dinis, P.. "Reply to Tomasz Drewa, Zbigniew Wolski and Janusz Tyloch's Letter to the Editor re: João Silva, Rui Pinto, Tiago Carvallho, et al. Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat. Eur Urol 2009;56:134-41". European Urology 56 5 (2009): http://www.scopus.com/inward/record.url?eid=2-s2.0-70349276709&partnerID=MN8TOARS.
    10.1016/j.eururo.2009.07.034
  172. Oliveira, R.; Silva, A.; Pinto, R.; Silva, J.; Silva, C.; Guimarães, M.; Dinis, P.; Cruz, F.. "Short-term assessment of a tension-free vaginal tape for treating female stress urinary incontinence". BJU International 104 2 (2009): 225-228. http://www.scopus.com/inward/record.url?eid=2-s2.0-67650644532&partnerID=MN8TOARS.
    10.1111/j.1464-410X.2008.08330.x
  173. Chapple C; Cruz F. "Open to debate. The Motion: antimuscarinics are the mainstay of therapy for overactive bladder.". (2008): http://europepmc.org/abstract/med/18439750.
    10.1016/j.eururo.2008.04.020
  174. Cruz F. "Editorial comment on: Effect of thalamic deep brain stimulation on lower urinary tract function.". (2008): http://europepmc.org/abstract/med/17686572.
    10.1016/j.eururo.2007.07.016
  175. Cruz, C.D.; Charrua, A.; Vieira, E.; Valente, J.; Avelino, A.; Cruz, F.. "Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals". Experimental Neurology 214 2 (2008): 301-308. http://www.scopus.com/inward/record.url?eid=2-s2.0-56349119753&partnerID=MN8TOARS.
    10.1016/j.expneurol.2008.08.016
  176. Dinis, P.; Cruz, F.. "Intravesical strategies to manage the neurogenic bladder". Current Bladder Dysfunction Reports 3 3 (2008): 133-139. http://www.scopus.com/inward/record.url?eid=2-s2.0-84873292882&partnerID=MN8TOARS.
    10.1007/s11884-008-0021-8
  177. Silva, J.; Silva, C.; Saraiva, L.; Silva, A.; Pinto, R.; Dinis, P.; Cruz, F.. "Intraprostatic Botulinum Toxin Type A Injection in Patients Unfit for Surgery Presenting with Refractory Urinary Retention and Benign Prostatic Enlargement. Effect on Prostate Volume and Micturition Resumption". European Urology 53 1 (2008): 153-159. http://www.scopus.com/inward/record.url?eid=2-s2.0-36448952295&partnerID=MN8TOARS.
    10.1016/j.eururo.2007.08.050
  178. Charrua, A.; Reguenga, C.; Paule, C.C.; Nagy, I.; Cruz, F.; Avelino, A.. "Cystitis is associated with TRPVIb-downregulation in rat dorsal root ganglia". NeuroReport 19 15 (2008): 1469-1472. http://www.scopus.com/inward/record.url?eid=2-s2.0-53549103863&partnerID=MN8TOARS.
    10.1097/WNR.0b013e32830f1e73
  179. Botelho, F.; Silva, P.; Tomada, N.; Sousa, T.; Cruz, F.. "Laparoscopic partial nephroureterectomy for duplex kidney and ureter with megaureter serving a hydronephrotic excluded upper pole: A case report". UroToday International Journal 1 4 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-84855919249&partnerID=MN8TOARS.
    10.3834/uij.1939-4810.2008.10.02
  180. Cruz, C.D.; Ferreira, D.; Mcmahon, S.B.; Cruz, F.. "The activation of the ERK pathway contributes to the spinal c-fos expression observed after noxious bladder stimulation". Somatosensory and Motor Research 24 1-2 (2007): 15-20. http://www.scopus.com/inward/record.url?eid=2-s2.0-34547865090&partnerID=MN8TOARS.
    10.1080/08990220601143265
  181. Cruz, C.D.; Cruz, F.. "The ERK 1 and 2 pathway in the nervous system: From basic aspects to possible clinical applications in pain and visceral dysfunction". Current Neuropharmacology 5 4 (2007): 244-252. http://www.scopus.com/inward/record.url?eid=2-s2.0-37249085110&partnerID=MN8TOARS.
    10.2174/157015907782793630
  182. Charrua, A.; Cruz, C.D.; Cruz, F.; Avelino, A.. "Transient Receptor Potential Vanilloid Subfamily 1 is Essential for the Generation of Noxious Bladder Input and Bladder Overactivity in Cystitis". Journal of Urology 177 4 (2007): 1537-1541. http://www.scopus.com/inward/record.url?eid=2-s2.0-33947262029&partnerID=MN8TOARS.
    10.1016/j.juro.2006.11.046
  183. Cruz, F.. "Re: Liu L, Mansfield KJ, Kristiana I, et al. 2007. The molecular basis of urgency: Regional difference of vanilloid receptor expression in the human urinary bladder. Neurourol Urodynam 26:433-438". Neurourology and Urodynamics 26 3 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34248143386&partnerID=MN8TOARS.
    10.1002/nau.20419
  184. Baiou, D.; Santha, P.; Avelino, A.; Charrua, A.; Bacskai, T.; Matesz, K.; Cruz, F.; Nagy, I.. "Erratum: Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice (Journal of Comparative Neurology (2007) 503, (334-347))". Journal of Comparative Neurology 504 5 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-35348838403&partnerID=MN8TOARS.
    10.1002/cne.21456
  185. Silva, C.; Silva, J.; Castro, H.; Reis, F.; Dinis, P.; Avelino, A.; Cruz, F.. "Bladder sensory desensitization decreases urinary urgency". BMC Urology 7 (2007): http://www.scopus.com/inward/record.url?eid=2-s2.0-34347407675&partnerID=MN8TOARS.
    10.1186/1471-2490-7-9
  186. Baiou, D.; Santha, P.; Avelino, A.; Charrua, A.; Bacskai, T.; Matesz, K.; Cruz, F.; Nagy, I.. "Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice". Journal of Comparative Neurology 503 2 (2007): 334-347. http://www.scopus.com/inward/record.url?eid=2-s2.0-34447650771&partnerID=MN8TOARS.
    10.1002/cne.21389
  187. Cruz, F.; Dinis, P.. "Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms". Neurourology and Urodynamics 26 6 SUPPL. (2007): 920-927. http://www.scopus.com/inward/record.url?eid=2-s2.0-35148889475&partnerID=MN8TOARS.
    10.1002/nau.20479
  188. Cruz, C.D.; McMahon, S.B.; Cruz, F.. "Spinal ERK activation contributes to the regulation of bladder function in spinal cord injured rats". Experimental Neurology 200 1 (2006): 66-73. http://www.scopus.com/inward/record.url?eid=2-s2.0-33746098867&partnerID=MN8TOARS.
    10.1016/j.expneurol.2006.01.016
  189. Dickson, A.; Avelino, A.; Cruz, F.; Ribeiro-da-Silva, A.. "Erratum to "Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis". [Neuroscience 139 (2006) 671-685]". Neuroscience 141 3 (2006): http://www.scopus.com/inward/record.url?eid=2-s2.0-33746398417&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2006.06.006
  190. Szallasi, A.; Cruz, F.; Geppetti, P.. "TRPV1: a therapeutic target for novel analgesic drugs?". Trends in Molecular Medicine 12 11 (2006): 545-554. http://www.scopus.com/inward/record.url?eid=2-s2.0-33750358054&partnerID=MN8TOARS.
    10.1016/j.molmed.2006.09.001
  191. Avelino, A.; Cruz, F.. "TRPV1 (vanilloid receptor) in the urinary tract: Expression, function and clinical applications". Naunyn-Schmiedeberg's Archives of Pharmacology 373 4 (2006): 287-299. http://www.scopus.com/inward/record.url?eid=2-s2.0-33745726257&partnerID=MN8TOARS.
    10.1007/s00210-006-0073-2
  192. Dickson, A.; Avelino, A.; Cruz, F.; Ribeiro-da-Silva, A.. "Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis". Neuroscience 139 2 (2006): 671-685. http://www.scopus.com/inward/record.url?eid=2-s2.0-33645870442&partnerID=MN8TOARS.
    10.1016/j.neuroscience.2005.11.050
  193. Cruz, F.; Silva, C.. "Refractory neurogenic detrusor overactivity". International Journal of Clinical Practice 60 SUPPL. 151 (2006): 22-26. http://www.scopus.com/inward/record.url?eid=2-s2.0-33751332525&partnerID=MN8TOARS.
    10.1111/j.1742-1241.2006.01182.x
  194. Cruz, C.D.; Avelino, A.; McMahon, S.B.; Cruz, F.. "Increased spinal cord phosphorylation of extracellular signal-regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation". European Journal of Neuroscience 21 3 (2005): 773-781. http://www.scopus.com/inward/record.url?eid=2-s2.0-14944352755&partnerID=MN8TOARS.
    10.1111/j.1460-9568.2005.03893.x
  195. Dinis, P.; Charrua, A.; Avelino, A.; Nagy, I.; Quintas, J.; Ribau, U.; Cruz, F.. "The distribution of sensory fibers immunoreactive for the TRPV1 (capsaicin) receptor in the human prostate". European Urology 48 1 (2005): 162-167. http://www.scopus.com/inward/record.url?eid=2-s2.0-20644439327&partnerID=MN8TOARS.
    10.1016/j.eururo.2005.01.009
  196. Cruz, C.D.; Neto, F.L.; Castro-Lopes, J.; McMahon, S.B.; Cruz, F.. "Inhibition of ERK phosphorylation decreases nociceptive behaviour in monoarthritic rats". Pain 116 3 (2005): 411-419. http://www.scopus.com/inward/record.url?eid=2-s2.0-21844449963&partnerID=MN8TOARS.
    10.1016/j.pain.2005.05.031
  197. Silva, C.; Silva, J.; Ribeiro, M.-J.; Avelino, A.; Cruz, F.. "Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: Results of a double-blind randomized placebo-controlled trial". European Urology 48 4 (2005): 650-655. http://www.scopus.com/inward/record.url?eid=2-s2.0-24644449231&partnerID=MN8TOARS.
    10.1016/j.eururo.2005.04.012
  198. Dinis, P.; Silva, J.; Ribeiro, M.J.; Avelino, A.; Reis, M.; Cruz, F.. "Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: A pilot study". European Urology 46 1 (2004): 88-94. http://www.scopus.com/inward/record.url?eid=2-s2.0-2942525673&partnerID=MN8TOARS.
    10.1016/j.eururo.2004.01.016
  199. Cruz, F.; Silva, C.. "Botulinum toxin in the management of lower urinary tract dysfunction: Contemporary update". Current Opinion in Urology 14 6 (2004): 329-334. http://www.scopus.com/inward/record.url?eid=2-s2.0-8644235669&partnerID=MN8TOARS.
    10.1097/00042307-200411000-00006
  200. Dinis, P.; Charrua, A.; Avelino, A.; Yaqoob, M.; Bevan, S.; Nagy, I.; Cruz, F.. "Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis". Journal of Neuroscience 24 50 (2004): 11253-11263. http://www.scopus.com/inward/record.url?eid=2-s2.0-10644240899&partnerID=MN8TOARS.
    10.1523/JNEUROSCI.2657-04.2004
  201. Tomada, N.; Vendeira, P.; Cruz, F.. "Erectile Dysfunction in patients with terminal chronic renal insuficiency on hemodialysis | Disfunção Eréctil em doentes com insuficiência renal crónica terminal em hemodiálise". Arquivos de Medicina 18 4 (2004): http://www.scopus.com/inward/record.url?eid=2-s2.0-17444387080&partnerID=MN8TOARS.
  202. Cruz, F.. "Mechanisms involved in new therapies for overactive bladder". Urology 63 3 SUPPL. 1 (2004): 65-73. http://www.scopus.com/inward/record.url?eid=2-s2.0-1542298215&partnerID=MN8TOARS.
    10.1016/j.urology.2003.11.001
  203. Dinis, P.; Charrua, A.; Avelino, A.; Cruz, F.. "Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders". BJU International 94 1 (2004): 153-157. http://www.scopus.com/inward/record.url?eid=2-s2.0-3242772894&partnerID=MN8TOARS.
    10.1111/j.1464-4096.2004.04855.x
  204. Sathianathan, V.; Avelino, A.; Charrua, A.; Santha, P.; Matesz, K.; Cruz, F.; Nagy, I.. "Insulin induces cobalt uptake in a subpopulation of rat cultured primary sensory neurons". European Journal of Neuroscience 18 9 (2003): 2477-2486. http://www.scopus.com/inward/record.url?eid=2-s2.0-0344011522&partnerID=MN8TOARS.
    10.1046/j.1460-9568.2003.03004.x
  205. Francisco Cruz; Paulo Diniz; António Avelino; Joao Silva. "Bladder overactivity and allodynia caused by chronic inflammation is mediated by vanilloid-sensitive primary afferent fibres". European Urology Supplements 1 1 (2002): 25-25. http://dx.doi.org/10.1016/s1569-9056(02)80087-2.
    10.1016/s1569-9056(02)80087-2
  206. Avelino, A.; Cruz, C.; Nagy, I.; Cruz, F.. "Vanilloid receptor 1 expression in the rat urinary tract". Neuroscience 109 4 (2002): 787-798. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037154961&partnerID=MN8TOARS.
    10.1016/S0306-4522(01)00496-1
  207. Silva, C.; Ribeiro, M.J.; Cruz, F.; Silva C; Ribeiro MJ; Cruz F. "The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input". Journal of Urology 168 2 (2002): 575-579. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036077240&partnerID=MN8TOARS.
    10.1016/S0022-5347(05)64683-6
  208. Avelino, A.; Cruz, C.; Cruz, F.. "Nerve growth factor regulates galanin and c-jun overexpression occurring in dorsal root ganglion cells after intravesical resiniferatoxin application". Brain Research 951 2 (2002): 264-269. http://www.scopus.com/inward/record.url?eid=2-s2.0-0037019866&partnerID=MN8TOARS.
    10.1016/S0006-8993(02)03171-2
  209. Cruz, F.. "Vanilloid receptor and detrusor instability". Urology 59 5 SUPPL. 1 (2002): 51-60. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036238329&partnerID=MN8TOARS.
    10.1016/S0090-4295(01)01638-7
  210. Naber, K.G.; Bergman, B.; Bishop, M.C.; Bjerklund-Johansen, T.E.; Botto, H.; Lobel, B.; Cruz, F.J.; Selvaggi, F.P.. "EAU guidelines for the management of urinary and male genital tract infections: Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)". European Urology 40 5 (2001): 576-588. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035732127&partnerID=MN8TOARS.
    10.1159/000049840
  211. Silva, C.; Avelino, A.; Souto-Moura, C.; Cruz, F.. "A light- and electron-microscopic histopathological study of human bladder mucosa after intravesical resiniferatoxin application". BJU International 88 4 (2001): 355-360. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035693147&partnerID=MN8TOARS.
    10.1046/j.1464-410X.2001.02339.x
  212. Silva, C.; Rio, M.E.; Cruz, F.. "Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia.". European Urology 38 4 (2000): 444-452. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034305393&partnerID=MN8TOARS.
  213. Avelino, A.; Cruz, F.. "Peptide immunoreactivity and ultrastructure of rat urinary bladder nerve fibers after topical desensitization by capsaicin or resiniferatoxin". Autonomic Neuroscience: Basic and Clinical 86 1-2 (2000): 37-46. http://www.scopus.com/inward/record.url?eid=2-s2.0-0034727918&partnerID=MN8TOARS.
    10.1016/S1566-0702(00)00204-6
  214. Vendeira, P.; Guimarães, M.; Silva, C.; Cruz, F.; Reis, M.. "Extra-adrenal pheochromocytoma and renal cell carcinoma: An unusual case of tumour synchronism". Scandinavian Journal of Urology and Nephrology 33 2 (1999): 133-135. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032587582&partnerID=MN8TOARS.
    10.1080/003655999750016159
  215. Avelino, A.; Cruz, F.; Coimbra, A.. "Intravesical resiniferatoxin desensitizes rat bladder sensory fibres without causing intense noxious excitation. A c-fos study". European Journal of Pharmacology 378 1 (1999): 17-22. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032799138&partnerID=MN8TOARS.
    10.1016/S0014-2999(99)00451-3
  216. Cruz, F.. "Symptoms of the lower urinary tract which suggest cystitis | Os sintomas do aparelho urinário baixo que lembram cistite.". Acta médica portuguesa 12 1-3 (1999): 19-21. http://www.scopus.com/inward/record.url?eid=2-s2.0-0032619819&partnerID=MN8TOARS.
  217. Cruz, F.. "Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders". International Urogynecology Journal 9 4 (1998): 214-220. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031658963&partnerID=MN8TOARS.
    10.1007/BF01901607
  218. Avelino, A.; Cruz, F.; Coimbra, A.. "Lidocaine prevents noxious excitation of bladder afferents induced by intravesical capsaicin without interfering with the ensuing sensory desensitization: An experimental study in the rat". Journal of Urology 159 2 (1998): 567-570. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031985898&partnerID=MN8TOARS.
    10.1016/S0022-5347(01)63985-5
  219. Cruz, F.; Guimarães, M.; Silva, C.; Rio, M.E.; Coimbra, A.; Reis, M.. "Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction". Journal of Urology 157 2 (1997): 585-589. http://www.scopus.com/inward/record.url?eid=2-s2.0-18544405115&partnerID=MN8TOARS.
    10.1016/S0022-5347(01)65211-X
  220. Avelino, A.; Cruz, F.; Coimbra, A.. "Sites of renal pain processing in the rat spinal cord. A c-fos study using a percutaneous method to perform ureteral obstruction". Journal of the Autonomic Nervous System 67 1-2 (1997): 60-66. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031551974&partnerID=MN8TOARS.
    10.1016/S0165-1838(97)00105-7
  221. Cruz, F.; Guimarães, M.; Silva, C.; Reis, M.. "Suppression of bladder hyperreflexia by intravesical resiniferatoxin [8]". Lancet 350 9078 (1997): 640-641. http://www.scopus.com/inward/record.url?eid=2-s2.0-0342437490&partnerID=MN8TOARS.
  222. Cruz, F.; Avelino, A.; Coimbra, A.. "Desensitization follows excitation of bladder primary afferents by intravesical capsaicin, as shown by c-fos activation in the rat spinal cord". Pain 64 3 (1996): 553-557. http://www.scopus.com/inward/record.url?eid=2-s2.0-0030003938&partnerID=MN8TOARS.
    10.1016/0304-3959(95)00157-3
  223. Pignatelli, D.; Falcão, H.; Coimbra-Peixoto, A.; Cruz, F.. "Unilateral adrenal hyperplasia". Southern Medical Journal 87 6 (1994): 664-667. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028361409&partnerID=MN8TOARS.
    10.1097/00007611-199406000-00017
  224. Cruz, F.; Avelino, A.; Lima, D.; Coimbra, A.. "Activation of the c-fos proto-oncogene in the spinal cord following noxious stimulation of the urinary bladder". Somatosensory & Motor Research 11 4 (1994): 319-325. http://www.scopus.com/inward/record.url?eid=2-s2.0-0028610302&partnerID=MN8TOARS.
    10.3109/08990229409028876
  225. Cruz, F.; Lima, D.; Coimbra, A.. "Periterminal synaptic organization of primary afferents in laminae I and IIo of the rat spinal cord, as shown after anterograde HRP labelling". Journal of Neurocytology 22 3 (1993): 191-204. http://www.scopus.com/inward/record.url?eid=2-s2.0-0027511239&partnerID=MN8TOARS.
    10.1007/BF01246358
  226. Merighi, A.; Cruz, F.; Coimbra, A.. "Immunocytochemical staining of neuropeptides in terminal arborization of primary afferent fibers anterogradely labeled and identified at light and electron microscopic levels". Journal of Neuroscience Methods 42 1-2 (1992): 105-113. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026522731&partnerID=MN8TOARS.
    10.1016/0165-0270(92)90140-9
  227. Cruz, F.; Morais, A.; Lindoro, J.; Marques, R.. "Treatment of idiopathic oligospermia with antiestrogens | TRATAMENTO DA OLIGOZOOSPERMIA IDIOPATICA COM ANTI-ESTROGENEOS". Arquivos de Medicina 5 3 (1992): 151-153. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026513307&partnerID=MN8TOARS.
  228. Cruz, F.; Lima, D.; Zieglgänsberger, W.; Coimbra, A.. "Fine structure and synaptic architecture of HRP-labelled primary afferent terminations in lamina IIi of the rat dorsal horn". Journal of Comparative Neurology 305 1 (1991): 3-16. http://www.scopus.com/inward/record.url?eid=2-s2.0-0026062468&partnerID=MN8TOARS.
    10.1002/cne.903050103
  229. Cruz, F.; Lima, D.; Coimbra, A.. "Several morphological types of terminal arborizations of primary afferents in laminae I-II of the rat spinal cord, as shown after HRP labeling and golgi impregnation". Journal of Comparative Neurology 261 2 (1987): 221-236. http://www.scopus.com/inward/record.url?eid=2-s2.0-0023267803&partnerID=MN8TOARS.
    10.1002/cne.902610205
  230. Lindoro, J.; Castro, JoseC.; Cruz, F.; Marques, R.. "TREATMENT OF PRIAPISM". The Lancet 324 8415 (1984): http://www.scopus.com/inward/record.url?eid=2-s2.0-0021679626&partnerID=MN8TOARS.
    10.1016/S0140-6736(84)90865-1
Capítulo de livro
  1. Silva, J.; Cruz, F.. "Botulinum toxin injections in the bladder and urethral sphincter". 291-298. 2019.
  2. Gao, Y.; Sanford, M.; Cruz, F.; Ginsberg, D.. "Minimally invasive treatments". 387-404. 2018.
  3. Charrua, A.; Cruz, F.. "TRP channels in the urinary bladder and prostate: Implications for therapy". 243-258. 2011.
Livro
  1. Avelino, A.; Cruz, F.; Panicker, J.N.; Liechti, M.D.. Basic principles. 2016.
    10.1007/978-3-319-25430-2_1
  2. Charrua, A.; Cruz, F.. Intravesical Capsaicin and Resiniferatoxin for Bladder Disorders. 2015.
    10.1016/B978-0-12-420024-1.00007-2
  3. Charrua, A.; Cruz, F.. TRP channels in the genitourinary tract. 2012.
    10.1007/978-1-62703-077-9_19
  4. Charrua, A.; Avelino, A.; Cruz, F.. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A. 2011.
    10.1007/978-3-642-16499-6_17
  5. Avelino, A.; Cruz, F.. TRPV1 in Visceral Pain and Other Visceral Disorders. 2010.
    10.1002/9780470588284.ch8
Pré-impressão
  1. Demetriou L; Krassowski M; Mendes PA; Garbutt K; Vitonis AF; Wilkins E; Coxon L; et al. "Clinical profiling of specific diagnostic subgroups of women with chronic pelvic pain". 2022. http://europepmc.org/abstract/PPR/PPR553750.
    10.1101/2022.10.03.22280515

Outros

Outra produção
  1. Biomarkers in the Overactive Bladder Syndrome. Urinary Incontinence. 2012. Duarte, Clia; Antunes, Tiago; Silva, Carlos; Cruz, Francisco. http://dx.doi.org/10.5772/35420.
    10.5772/35420
  2. TRPV1 agonist therapies in bladder diseases. 2005. Francisco Cruz; Carlos Silva; Paulo Dinis. http://dx.doi.org/10.1007/3-7643-7379-2_11.
    10.1007/3-7643-7379-2_11
Atividades

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2018 - 2018 Chronic stress induces bladder pain through a NGF dependent mechanism  
Orientador
 Medicina (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
2015 - 2015 Lower Urinary Tract Symptoms and Aging: the impact of chronic bldder ischemi on Overctive Bladder Syndrome
Orientador
 Medicina (Mestrado)
Universidade do Porto Faculdade de Medicina, Portugal
2012 - 2012 Tratamento cirúrgico da incontinência urinária de esforço feminina com fitas sub-uretrais de incisão única vaginal
Coorientador
 Medicina (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2011 - 2011 Avaliação Morfológica e funcional da função endotelial peniana e sistémica em contexto de disfunção eréctil
Coorientador
 Medicina (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2008 - 2008 Tratamento da Hiperactividade Vesical de Causa Neurogénicas e Não Neurogénica pela Dessensibilização Vesical
Orientador
 Medicina (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2006 - 2006 Papel do Receptor Vanilóide de Tipo 1 (trpv1) para a Hiperactividade Vesical
Orientador
 Medicina (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
Distinções

Prémio

2018 1st Grunenthal Prize on Clinical Pain Research and Therapy
Fundação Grünenthal, Portugal
2018 First prize of ICS 2018 abstracts on the topic of urethra
International Continence Society, Reino Unido
2016 3rd Best Poster

Outra distinção

2015 Best poster (poster session)
2015 Honorary member of the New York section of America Urology Association
2014 Best Poster Session
2014 Pain Research Award
2011 Best non-oncological poster of XXVI EAU Congress
East Africa University, Somália
2010 Premio melhor Poster de incontinencia urinária
European Association of Urology, Países Baixos
2010 Prémio para o Melhor Poster
Astor Services for Children & Families, Estados Unidos
2010 Premio melhor Poster
2010 Top Reviewer
2009 Melhor poster do Congresso Poruguês de Urologia
Azim Premji University, Índia
2009 Revisor do Mês (Agosto)
2009 Pain Research and Therapy Award
2008 Melhor poster
European Association of Urology, Países Baixos
2008 Menção Honrosa - Prémio Grunenthal para o estudo da Dor
2007 Melhor poster
European Association of Urology, Países Baixos
2007 Prémio Grunenthal para o estudo da Dor
2006 Prémio Grunenthal para o estudo da Dor
2004 Prémio Grunenthal para o estudo da Dor
2004 First prize to Book Neurogenix Bladder: adults and children
British Medical Association, Reino Unido
2004 Prémio APU para o melhor artigo científico
Associação Portuguesa de Urologia, Portugal
2004 Prémio APU para o melhor projecto de investigação clínica
Associação Portuguesa de Urologia, Portugal
2003 Prémio Grunenthal para o estudo da Dor
2001 Melhor poster
European Association of Urology, Países Baixos
1999 Prémio Grunenthal para o estudo da Dor
1998 Prémio APU para o melhor projecto de investigação básica
Associação Portuguesa de Urologia, Portugal
1995 Segundo prémio do Congresso Nacional de Urologia
1993 Primeiro prémio do Congresso Nacional de Urologia
1990 Menção Honrosa do Congresso Nacional de Urologia
1985 Menção Honrosa do Congresso Nacional de Urologia